Engineering effective T-cell based antitumor immunity.

about

Trial Watch: Adoptive cell transfer for oncological indications Modulation of Immune Cell Functions by the E3 Ligase Cbl-b.Angiopep-2/IP10-EGFRvIIIscFv modified nanoparticles and CTL synergistically inhibit malignant glioblastoma

P2860

Q26785545-E43B8533-F8C5-414C-AAC5-7925CAFE686E Q38393275-EBF2986E-2AB7-4FFD-8C9D-83DD5BD116B2 Q58701542-A88CFFF1-8E25-4316-B250-939495935F82

P2860

Engineering effective T-cell based antitumor immunity.

Item

http://www.wikidata.org/entity/Q43225888

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Engineering effective T-cell based antitumor immunity.

@en

Engineering effective T-cell based antitumor immunity.

@nl

type

Item

label

Engineering effective T-cell based antitumor immunity.

@en

Engineering effective T-cell based antitumor immunity.

@nl

prefLabel

Engineering effective T-cell based antitumor immunity.

@en

Engineering effective T-cell based antitumor immunity.

@nl

P1476

Engineering effective T-cell based antitumor immunity.

@en

P2093

Christa Pfeifhofer-Obermair

http://www.w3.org/2001/XMLSchema#string

Dominik Wolf

http://www.w3.org/2001/XMLSchema#string

Gottfried Baier

http://www.w3.org/2001/XMLSchema#string

Reinhard Hinterleitner

http://www.w3.org/2001/XMLSchema#string

Thomas Gruber

http://www.w3.org/2001/XMLSchema#string

P2860

Adoptive transfer of siRNA Cblb-silenced CD8+ T lymphocytes augments tumor vaccine efficacy in a B16 melanoma model

Ablation of Cbl-b provides protection against transplanted and spontaneous tumors.

Spontaneous tumor rejection by cbl-b-deficient CD8+ T cells

Reinforcement of cancer immunotherapy by adoptive transfer of cblb-deficient CD8+ T cells combined with a DC vaccine.

Essential role of E3 ubiquitin ligase activity in Cbl-b-regulated T cell functions.

Cutting edge: deficiency in the E3 ubiquitin ligase Cbl-b results in a multifunctional defect in T cell TGF-beta sensitivity in vitro and in vivo.

Cbl-b regulates the CD28 dependence of T-cell activation.

Resistance to CD4+CD25+ regulatory T cells and TGF-beta in Cbl-b-/- mice.

Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b

P304

e22893

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/ONCI.22893

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236077724

http://www.w3.org/2001/XMLSchema#string

P698

23525844

http://www.w3.org/2001/XMLSchema#string

P932

3601162

http://www.w3.org/2001/XMLSchema#string

Engineering effective T-cell based antitumor immunity.

about

P2860

P2860

Engineering effective T-cell based antitumor immunity.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932